Mbia Inc.
—- Market cap
- $243.35M
- Debt
- +$4.17B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 6% equity / 94% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $243.35M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: MBI stock price at discount vs CTMX $4.77 current versus $16.64 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTMX's multiple
Implied fair value · at MBI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MBI FY 2025 (ended Dec 31, 2025) · CTMX FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 6% equity / 94% debt
Capital structure 98% equity / 2% debt · EV / Revenue 10.66x
MBI carries the larger enterprise value at $4.41B against $812.63M; CTMX trades on the lower EV / Revenue multiple (10.66x vs 55.18x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MBIA INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
CytomX Therapeutics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-1.86x
0.17x
Net debt / EBITDA
Leverage against operating earnings
—
-0.27x
Cash and equivalents
Liquid reserves on the balance sheet
—
$12.67M
Total debt
Interest-bearing obligations outstanding
$4.17B
$16.89M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ASSURED GUARANTY LTD
MBI vs AGO
RADIAN GROUP INC
MBI vs RDN
AXIS CAPITAL HOLDINGS LTD
MBI vs AXS
CNA FINANCIAL CORP
MBI vs CNA
IDEAYA Biosciences, Inc.
MBI vs IDYA
EXELIXIS, INC.
MBI vs EXEL
GILEAD SCIENCES, INC.
MBI vs GILD
AMGEN INC
MBI vs AMGN
AbbVie Inc.
MBI vs ABBV
BRISTOL MYERS SQUIBB CO
MBI vs BMY
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.